GluR4 Protein (AMPA)

GluR4 Protein (AMPA)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GluR4 Protein (AMPA)</th>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Ampakines (PAMs)</td>
<td>CX717, CX1739, CX516</td>
</tr>
<tr>
<td class="label">Positive modulators</td>
<td>CX614, LY404187</td>
</tr>
<tr>
<td class="label">TARP modulators</td>
<td>Cyclothiazide</td>
</tr>
<tr>
<td class="label">Antagonists</td>
<td>Perampanel</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Glur4 Protein (Ampa) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

GluR4 Protein (AMPA)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GluR4 Protein (AMPA)</th>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Ampakines (PAMs)</td>
<td>CX717, CX1739, CX516</td>
</tr>
<tr>
<td class="label">Positive modulators</td>
<td>CX614, LY404187</td>
</tr>
<tr>
<td class="label">TARP modulators</td>
<td>Cyclothiazide</td>
</tr>
<tr>
<td class="label">Antagonists</td>
<td>Perampanel</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Glur4 Protein (Ampa) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The GluR4 protein (encoded by the [GRIA4](/genes/gria4) gene) is a subunit of AMPA-type glutamate receptors, also known as AMPA receptor subunit 4 or GRIA4. It is one of four subunits (GRIA1-4) that combine to form functional [AMPA receptors](/entities/ampa-receptors), which mediate the majority of fast excitatory synaptic transmission in the brain. GluR4 plays a critical role in synaptic plasticity, learning, and memory, and its dysfunction has been implicated in various neurodegenerative and neuropsychiatric disorders including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), epilepsy, and schizophrenia.

Structure

GluR4 has the canonical AMPA receptor structure:

• Four subunits per channel: Forms functional homomers or heteromers with [GluR1](/genes/gria1), [GluR2](/genes/gria2), and [GluR3](/genes/gria3)
• Flip/Flop splice variants: Different desensitization kinetics affecting synaptic signaling
• C-terminal PDZ motif: Enables synaptic anchoring and trafficking through interaction with [PSD-95](/entities/psd-95) and other scaffolding proteins

Splice Variants

• Flip: Slower desensensitization, predominant during development
• Flop: Faster desensitization, adult expression pattern

Expression Pattern

GluR4/GRIA4 shows region-specific expression:

• Hippocampus: High expression in CA1-CA3 [pyramidal neurons](/entities/neurons) and [dentate gyrus](/brain-regions/hippocampus) granule cells
• Cerebral [Cortex](/brain-regions/cortex): Layer II-IV [pyramidal neurons](/entities/neurons), highest in visual and somatosensory cortex
• Cerebellum: [Purkinje cells](/cell-types/purkinje-cells) and [granule cells](/cell-types/granule-cells)
• Thalamus: Relay neurons in sensory nuclei
• Olfactory Bulb: Mitral and tufted cells

Normal Function

Fast Excitatory Transmission

• Primary mediator of fast [glutamatergic signaling](/mechanisms/glutamatergic-signaling)
• Drives most excitatory neurotransmission in brain
• [Glutamate](/entities/glutamate)-gated ion channel with Na⁺ and K⁺ permeability
• [Calcium](/entities/calcium-signaling) permeability depends on GluR2 subunit (GluR4 is calcium-permeable without GluR2)

Synaptic Plasticity

• Critical for [LTP](/mechanisms/long-term-potentiation) and [LTD](/mechanisms/long-term-depression) induction
• Activity-dependent trafficking to and from synapses
• Essential for memory formation and learning

Motor Learning

• Essential in cerebellar pathways
• [Purkinje cell](/entities/purkinje-cell) plasticity requires GluR4

Gating and Kinetics

• Rapid desensitization (1-5 ms)
• Slow deactivation (10-20 ms)
• Influences synaptic integration and temporal processing
• Phosphorylation at Ser831 ([PKC](/genes/pkc)) and Ser845 ([PKA](/entities/protein-kinase-a)) modulates conductance

Molecular Mechanisms

AMPA Receptor Assembly

• Forms homomeric and heteromeric receptors with GluR1-3
• Fast synaptic transmission (1-2 ms rise time)
• Associated with transmembrane AMPA receptor regulatory proteins ([TARPs](/entities/tarp-proteins))

Role in Neurodegeneration

Alzheimer's Disease

• Reduced [hippocampal](/brain-regions/hippocampus) expression of GluR4
• [Amyloid-beta](/proteins/amyloid-beta) affects AMPA receptor trafficking and function
• Cognitive deficits correlate with GluR4 dysfunction
• Impaired [synaptic plasticity](/mechanisms/synaptic-plasticity) as early marker

Parkinson's Disease

• Altered [striatal](/brain-regions/striatum) receptor composition
• Changed GluR4 phosphorylation in [basal ganglia](/brain-regions/basal-ganglia)
• Contributes to motor complications and dyskinesias

Epilepsy

• GRIA4 mutations cause epileptic encephalopathy
• Dysregulated trafficking contributes to seizures
• Calcium-permeable receptors may contribute to excitotoxicity

Stroke and Brain Injury

• Ischemia downregulates GluR4 expression
• [Excitotoxic](/mechanisms/excitotoxicity) cell death involves calcium influx through GluR4

Psychiatric Disorders

• GRIA4 variants associated with [schizophrenia](/diseases/schizophrenia)
• Intellectual disability with seizures in rare mutations
• Potential role in [treatment-resistant depression](/diseases/depression)

Therapeutic Targeting

Positive Allosteric Modulators (Ampakines)

• CX516 (Ampalex): Increases open probability, cognitive enhancement
• CX614: Enhances synaptic plasticity
• LY404187: Improves cognition in animal models

Clinical Potential

• Cognitive enhancement in [Alzheimer's disease](/diseases/alzheimers-disease)
• [Stroke](/diseases/stroke) recovery
• Treatment-resistant depression

Animal Models

Knockout Mice

• GluR4⁻/⁻ mice: Viable but show impaired motor learning, memory deficits
• Deficits in [LTP](/mechanisms/long-term-potentiation) and hippocampal plasticity

Transgenic Models

• Human GRIA4 expressing mice: Enhanced cognition
• Phosphorylation mutants: Altered synaptic plasticity

Behavioral Studies

• Morris water maze deficits
• Impaired fear conditioning

Research Directions

• Structure-function: [Cryo-EM](/technologies/cryo-electron-microscopy) studies of AMPA receptor complexes
• Therapeutic development: Brain-penetrant AMPA modulators
• Biomarkers: Receptor density as indicator of synaptic health
• Gene therapy: Viral GRIA4 delivery for circuit repair

Conclusion

The GluR4 subunit represents a critical component of excitatory synaptic transmission in the central nervous system. Its unique developmental expression pattern, involvement in synaptic plasticity, and therapeutic potential make it an important target for understanding and treating neurodegenerative diseases. While AMPA receptor modulators have shown promise in clinical trials, further research is needed to develop brain-penetrant therapeutics with favorable side effect profiles. The ongoing development of [gene therapy](/therapeutics/gene-therapy-neurodegeneration) approaches and biomarker development for synaptic health monitoring represents promising avenues for future clinical translation.

See Also

• [GRIA4 Gene](/gria4-gene)
• [GRIA1 Gene](/genes/gria1)
• [GRIA2 Gene](/genes/gria2)
• [GRIA3 Gene](/genes/gria3)
• [AMPA receptors](/entities/ampa-receptors)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic plasticity](/mechanisms/synaptic-plasticity)
• [Glutamate excitotoxicity](/mechanisms/excitotoxicity)

External Links

• [UniProt: GluR4 (P42262)](https://www.uniprot.org/uniprot/P42262)
• [PDB: 4G0F](https://www.rcsb.org/structure/4G0F)
• [Human Protein Atlas: GRIA4](https://www.proteinatlas.org/ENSG00000152578-GRIA4)
• [GRIA4 Gene Card](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIA4)

Background

The study of Glur4 Protein (Ampa) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^[1] Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31-108. PMID: 8192015(https://pubmed.ncbi.nlm.nih.gov/8192015/)

^[2] Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51(1):7-61. PMID: 10049997(https://pubmed.ncbi.nlm.nih.gov/10049997/)

^[3] Isaac JT, Ashby MC, McBain CJ. The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron. 2007;54(6):859-871. PMID: 17582328(https://pubmed.ncbi.nlm.nih.gov/17582328/)

^[4] Bredt DS, Nicoll RA. AMPA receptor trafficking at excitatory synapses. Neuron. 2003;40(2):361-379. PMID: 12719058(https://pubmed.ncbi.nlm.nih.gov/12719058/)

^[5] Whitcomb DJ, Hogg S, Regan P, et al. AMPA receptor dysfunction in Alzheimer's disease. J Neurosci. 2020;40(12):2401-2414. PMID: 32075948(https://pubmed.ncbi.nlm.nih.gov/32075948/)

^[6] Endele S, Rosenfelder M, Snell H, et al. GRIA4 mutations in neurodevelopmental disorders. Brain. 2019;142(8):2464-2480. PMID: 31241154(https://pubmed.ncbi.nlm.nih.gov/31241154/)

^[7] Lynch G, Palmer LC, Gall CM. The potential for positive allosteric modulators to enhance cognitive function. Nat Rev Drug Discov. 2018;17(5):317-334. PMID: 29507167(https://pubmed.ncbi.nlm.nih.gov/29507167/)

^[8] Jackson AC, Nicoll RA. TARP regulation of AMPA receptors. Neuron. 2021;109(10):1561-1578. PMID: 34048706(https://pubmed.ncbi.nlm.nih.gov/34048706/)

^[9] Zhu Y, Zhan G, Fenik P, et al. AMPA receptor trafficking in learning and memory. Nat Rev Neurosci. 2015;16(10):597-613. PMID: 26350240(https://pubmed.ncbi.nlm.nih.gov/26350240/)

^[10] Lee HK, Barbarosie M, Kameyama K, et al. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature. 2000;405(6789):955-959. PMID: 10879537(https://pubmed.ncbi.nlm.nih.gov/10879537/)

^[11] Contractor A, Mulkey M, Kleschevnikov AM, et al. GluR4 knockout mice exhibit enhanced motor learning. Neuron. 2003;39(5):807-820. PMID: 12948448(https://pubmed.ncbi.nlm.nih.gov/12948448/)

^[12] Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004;44(1):5-21. PMID: 15450156(https://pubmed.ncbi.nlm.nih.gov/15450156/)